EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY 4.0

Comment on article by Poostiyan et al.: Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor‐blind split‐face controlled trial

Menglei Wang, Chenyi Yang

Journal of Cosmetic Dermatology · 2023

DOI: 10.1111/jocd.15853 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Menglei Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tongxiang First People's Hospital, Jiaxing, China. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Melanosis, Tranexamic Acid. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsMelanosisTranexamic AcidHumansAdministration, CutaneousMicroinjectionsRandomized Controlled Trials as Topic

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • Department of Dermatology, Tongxiang First People's Hospital, Jiaxing, China.
  • Graduate school, Zhejiang Chinese Medical University, Hangzhou, China.

Zitieren

APA

Wang, M., & Yang, C. (2023). Comment on article by Poostiyan et al.: Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor‐blind split‐face controlled trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15853

Vancouver

Wang M, Yang C. Comment on article by Poostiyan et al.: Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor‐blind split‐face controlled trial. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15853

BibTeX
@article{Wang2023,
  author = {Wang, Menglei and Yang, Chenyi},
  title = {Comment on article by Poostiyan et al.: Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor‐blind split‐face controlled trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2023},
  doi = {10.1111/jocd.15853}
}
Kostenlos starten →